SciELO - Scientific Electronic Library Online

 
vol.24 número3Fifth peak of COVID-19 and use of masks in open and enclosed spaces índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Universidad y Salud

versão impressa ISSN 0124-7107versão On-line ISSN 2389-7066

Resumo

DIAZTAGLE-FERNANDEZ, Juan José et al. Gastrointestinal bleeding prophylaxis in internal medicine patients of a univeristy hospital. Univ. Salud [online]. 2022, vol.24, n.3, pp.273-278.  Epub 31-Ago-2022. ISSN 0124-7107.  https://doi.org/10.22267/rus.222403.282.

Introduction:

Anti-ulcer medications are frequently used in hospitalized patients, yet their use is not usually indicated.

Objective:

To describe the frequency of prescription and indication of medications to prevent gastrointestinal bleeding in hospitalized patients.

Materials and methods:

A cross-sectional, descriptive, prospective study was carried out in the Internal Medicine service of the Surgery Society of Bogota-San Jose Hospital of Bogota (Colombia). Excluded patients were those with either a gastrointestinal bleeding diagnosis or a history of allergy to anti-ulcer medications. Demographic data and information regarding prescribed medications were collected. It was determined whether the medicine indication was adequate and the type of prescription error was identified.

Results:

179 patients were included in the study, 57% (102) of which were women. The average age was 61.3 (±20.2) years old. Infectious disease was the main admission diagnosis (76; 42.4%). A 92.17% (165) of the total number of patients received medications to prevent gastrointestinal bleeding. This indication was adequate for 75 (41.89%) patients. The most frequent error was their use in bleeding low-risk patients (101; 97.1%).

Conclusion:

A high percentage of patients received medication to prevent gastrointestinal bleeding. However, in about half of these patients it was not indicated.

Palavras-chave : Ranitidine; omeprazole; disease prevention; gastrointestinal hemorrhage; guideline.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )